Functional studies can contribute to predict the pathogenicity of a novel mutation for cardiomyopathy

First of all, we thank Dr. Bermúdez-Jiménez and Dr. Jiménez-Jáimez for their comments [ [2] Bermúdez-Jiménez Francisco José Jiménez-Jáimez Juan Functional study is not the only criterion to predict the pathogenicity of a novel mutation for cardiomyopathy. J. Mol. Cell. Cardiol. 2016; : 2016 Google Scholar ] to our study characterizing the novel DES-p.L136P mutation in a patient with dilated cardiomyopathy (DCM) [ [3] Brodehl Andreas Dieding...